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Further Studies on the Toxicology
of the Glycol Ethers with Emphasis on
Rapid Screening and Hazard Assessment
by J. E. Doe*
The discovery that ethylene glycol monomethyl ether (EGME) could affect the testis and the developing
fetus in laboratory animals prompted further work to understand the effect of EGME and to examine
additional glycol ethers to see if they showed EGME's reprotoxicity.
Propylene glycol monomethyl ether (PGME) was shown not to cause testicular atrophy or to affect the
development of rats at 600 ppm by inhalation, whereas EGME caused testicular atrophy at 300 ppm and
showed teratogenic potential at 100 ppm.
Diethylene glycol monomethyl ether (diEGME) was found to show no teratogenic potential when
administered subcutaneously in rats at up to 1000 ,iL/kg, whereas EGME had effects at 40 ,iL/kg.
EGME has been shown to cause effects on the testis in rats after a single exposure to 600 ppm orabove for
4 hr. The effects can be seen as little as 24 hr after exposure. Ethylene glycol monoethyl ether (EGEE) also
causes a reduction in testicular weight following a single exposure to saturated vapor for 3 hr (17 mg/I), but
ethylene glycol monoisopropyl ether (EGPE) at 15 mg/l and ethylene glycol monobutyl ether (EGBE) at 4
mg/l showed no effect on the testis.
Introduction
The reproductive toxicology ofglycol ethers has been
the subject of much concern in recent years. This
concern was initiated by a report (1) describing testicu-
lar atrophy in mice dosed with ethyelene glycol mono-
methyl ether (EGME) and ethylene glycol monoethyl
ether (EGEE). Moreover, both EGME (2) and EGEE
(3) have been shown to cause fetotoxicity and/or terato-
genicity in laboratory animals. These observations lead
to a general reappraisal of the glycol ethers as a class
and this paper describes some of the work which was
carried out within Imperial Chemical Industries PLC in
order to determine the reproductive toxicology of
several members ofthe glycol ethers group which were
of proven or potential commercial importance. None of
the studies was conducted to full classical protocols, but
each one was designed to answer a specific question to
aid in either product development or in the development
of safe handling. In retrospect, this series of experi-
ments can be seen as a way in which toxicology can
provide useful data even though the studies are not
carried out to a regulatory protocol.
*ImperialChemicalIndustriesPLC, CentralToxicologyLaboratory,
Alderley Park, Macclesfield, Cheshire, UK.
Comparative ReproductiveToxicology
by Inhalation in Rats of Ethylene
Glycol Monomethyl (EGME) and
Propylene Glycol Monomethyl Ether
(PGME)
This study was carried out at a time when the effects
of EGME upon both the testes by inhalation (4) and its
effects ofthe fetus (2) were known. However, there were
no data available on the toxicology of PGME, and this
study was designed to assess whether PGME was
capable of causing the same effects on reproductive
toxicology as EGME. It was therefore important to use
EGME as a positive control for both the testicular
effects and the teratogenic effects. The study was
designed in two parts: effect on testis and hematology
and determination of teratogenic potential.
Effect on Testis and Hematology
Ten male rats ofthe Alpk/Ap (Wistar-derived) strain
were exposed to the following concentrations: 100 ppm
EGME, 300 ppm EGME, or 200 ppm PGME or 600 ppm
PGME for 6 hr/day for 10 consecutive days in 3.4 m3
inhalation chambers (5). During the exposure periodJ. E. DOE
the animals were periodically weighed and observed for
changes in their clinical condition or other behavioral
changes. Onthe dayafterthe 10th exposurethe animals
were killed by exposure to Fluothane. Blood samples
were taken for hematological assessment and the testis
weighed and removed and processed, along with the
thymus, into slides for subsequent histopathological
evaluation.
Thebody weightgain and absolute weights oftherats
exposed to 300 ppm EGME were significantly reduced;
however, 100 ppm EGME and 200 or 600 ppm PGME
had no effect on body weight. None of the treatments
caused any changes inclinicalobservations. Atpostmor-
tem there were no effects at 100 ppm EGME or at 200
and 600 ppm PGME, however, the thymus and the
testes of the rats exposed to 300 ppm EGME were
reduced in size (Fig. 1). In the blood samples taken at
postmortem 300 ppm of EGME was shown to cause a
reduction in total white blood cells, the number of red
blood cells and the hemaglobin concentration ofthe red
blood cells. There were no effects at 100 ppm EGME or
with either concentration ofPGME. Histological exami-
nation ofthe testis revealed a few seminiferous tubules
with disordered spermatogenesis with a similar inci-
dence in the controls and in rats exposed to 100 ppm
EGME, 200 ppm PGME or 600 PGME. Pronounced
tubular atrophy was seen in the testis from all the rats
exposed to 300 ppm EGME, where 70 to 100% of the
seminiferous tubules were affected.
Determination of Teratogenic Potential
In orderto provide arapid assessment ofthe effect of
PGME and EGME on the developing embryo when rats
were exposed by inhalation, an adaptation of the
procedure described by Chernoff and Kavlock (6) was
employed. Pregnant female rats, approximately 11 to 13
weeks of age, of the Alpk/Ap (Wistar-derived) strain
were used. Groups of20 rats pergroup were exposed to
air, 100or300 ppm EGME and 200 or600 ppm ofPGME
for6 hr/day on days 6to 17 (inclusive ofgestation, day of
mating being day 0). After the last exposure period the
rats were removed from the exposure chamber and
housed singly. The rats were allowed to deliver their
litters which were observed for 3 days. The number of
live and dead pups in each litter and the weight ofeach
litterwere determined on days 1 and 3 postpartum. Any
rats not producing litters by day 24 of gestation were
killed, and agross postmortem examination was carried
out to determine the status of pregnancy. All the rats
were pregnant: all the control rats and all the rats
exposed to PGME produced litters. Exposure to 300
ppm EGME caused a significant reduction in body
weight gain throughout the study, and none of these
rats produced litters. Only 9 of the 20 rats exposed to
100 ppm produced litters and in these rats the gestation
period was significantly increased to a mean value of
23.6 days from a control value of22 days. The compara-
tive litter data are shown in Thble 1. There was a
significant reduction in the proportion of live pups
initially and the proportion survivingfor3 days postpar-
tum in the litters ofdams exposed to 100 ppm EGME.
The weight of the pups in this group on day 1 was
similar to the controls, although they had gained
significantly less weight by day 3. All the pups were
normal externally. There was no evidence of any effect
in either of the groups exposed to PGME.
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FIGURE 1. Effect on testis weights of the inhalation of EGME and PGME for 10 consecutive days in male rats. Asterisks denote significantly
different from controls: (**) p < 0.01; (*) p < 0.05.
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Table 1. Comparative effect of EGME and PGME by inhalation on pregnant rats: litter data.
Group mean no. of Proportion of Proportion of Group mean Live pup
live and dead pups live pups pups surviving per litter, weight on
Treatment on day 1 (n) on day 1 to day 3 day 1 (n) day 3, g (n)
Control 11.5 ± 3.0 (20) 226/229 (98.7%) 223/226 (98.7%) 6.0 ± 0.5 (20) 7.2 ± 0.8 (20)
100 ppm EGME 3.3 ± 2.4 (9)t 23/30"t (76.7%) 16/23 (69.6%) 6.1 ± 0.6 (7) 6.3 ± 1.1 (4)
300 ppm EGME
200 ppm PGME 11.7 ± 2.0 (20) 231/233 (99.1%) 226/231 (97.8%) 6.0 ± 0.4 (20) 7.1 ± 0.7 (20)
600 ppm PGME 11.7 ± 2.6 (20) 228/233 (97.9%) 227/228 (99.6%) 6.0 ± 0.4 (20) 7.0 ± 0.7 (20)
tStatistically significantly different from the control group at the 1% level (Fisher's exact test, two-sided).
*Statistically significantly different from the control group at the 1% level (t-test, two-sided).
Conclusions
This experiment demonstrated that 300 ppm of
EGME caused hematological changes, testicular atro-
phy and thymic atrophy in male rats and complete
embryo lethality in pregnant female rats.A 100 ppm
level caused fetal mortality, fetotoxicity and the impair-
ment ofpostnatal development. This spectrum ofeffects
has been defined as describingteratogenic potential (6).
In contrast, neither 200 nor 600 ppm of PGME caused
any effects in either males or pregnant females. The
results of this preliminary study therefore indicate
clearly that PGME does not share the spectrum of
activity shown by EGME upon the reproductive process
at significant dose levels. The study has been described
previously (7).
Teratogenic Potential of Diethylene
Glycol Monomethyl Ether(diEGME) in
thePostnatal DevelopmentTestin Rats
Few or no data existed at the time this study was
carried out on the effect of diethylene glycol ethers on
the developing embryo. This study was carried out to
assess the effect ofdiethylene glycol monomethyl ether
(diEGME) on the rat fetus in order to determine
whether diEGME showed the same spectrum of activ-
ity as EGME, which would have meant reconsideration
of the way in which the compound is handled. The
postnatal development test (6) was used, as EGME had
already been shown to be positive in this test by
inhalation. As diEGME is relatively nonvolatile, human
exposure is more likely to be by dermal contact;
consequently diEGME was administered by the sub-
cutaneous route as this represents the worst case,
assuming the complete breakdown of the barrier func-
tion of the skin. Pregnant female Alpk/Ap (Wistar-
derived) rats 11 to 13 weeks ofage were mated and the
day on which spermatozoa were detected was taken as
day 0 of pregnancy. Groups of 15 rats were used and
they were injected subcutaneously with 2 mL of sterile
water containing the appropriate compounds on days 6
to 20 of gestation inclusive. The groups were controls,
250 puL/kg diEGME, 500 ,LL/kg diEGME, 1000 ,LL/kg
diEGME, 40 ,uL/kg EGME, 250 p1L/kg EGME. The
rats were observed daily for changes in clinical condi-
tion and weighed on day 1 and on each day between day
6 and 20. Each rat was allowed to litter and the
offspring weighed and the number ofdead and live pups
were recorded on days 1 and 4 postpartum. The female
rats and the pups were then killed. All animals which
failed to produce a litter by day 24 of pregnancy were
killed and the status of pregnancy determined.
No abnormalities in clinical condition were seen in
any of the rats treated with diEGME; however, some
of the rats treated with 250 p1L/kg EGME showed
piloerection and vaginal bleeding. The body weight gain
of these rats treated with 250 ,uL/kg EGME was
significantly reduced compared with controls. One con-
trol animal did not produce a litter and was found not to
be pregnant. None of the rats treated with 250 ,uL/kg
EGME produced litters, although they were all found to
have been pregnant.
The litter data are shown in Table 2, where it will be
seen that 40 puL/kg of EGME reduced the number of
litters as well as the number of live pups per litter and
the percentage of pups surviving for 4 days. EGME
therefore clearly showed its fetotoxic effect in this
study. diEGME, on the other hand, caused no maternal
toxicity and little or no effect on the development ofthe
young at 250 or 500 puL/kg. There was a slight, but not
statistically significant, decrease in the survivability in
the offspring of the rats treated with 1000 puL/kg, and
this may be indicative of a slight fetotoxic effect at this
high dose level. However, diEGME certainly does not
share the marked fetotoxicity shown by EGME, and, as
the route ofadministration was chosen to maximize the
possible effects of diEGME, it is unlikely that dermal
exposure to diEGME in humans would present a
significant risk. These data were reported previously
(8).
Effect on Route of Administration
on Teratogenic Potential of EGME
EGME has been shown to cause testicular atrophy
and/or fetotoxicity by a variety of routes such as
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Table 2. Effect of subcutaneous diEGME and EGME in pregnant rats: litter data.
diEGME diEGME diEGME EGME EGME
Control 250 ,uL/kg 500 ,L/kg 1000 ,uL/kg 40 ,uL/kg 250 ,uL/kg
No. pregnant 14/15 15/15 15/15 15/15 15/15 15/15
No. of litters 14 15 15 15 7 0
No. of live pups per litter ( ± SD) 11.7 ± 2.7 12.0 ± 1.9 10.9 ± 3.1 10.5 ± 3.6 3.7 ± 4.2k
Pup weight at day 1, g ( ± SD) 5.9 ± 0.6 6.0 ± 0.5 6.3* ± 0.4 6.2 ± 0.5 6.1 ± -/5
Pup weight at day 5, g ( ± SD) 8.5 ± 1.1 8.8 ± 1.2 9.3 ± 1.1 8.6 ± 1.1 10.4 ± 0.7*
Weight gain per pup, g ( ± SD) 2.5 ± 0.8 2.8 ± 0.8 3.0 ± 1.0 2.4 ± 0.9 3.6 ± 0.2
No. live pups per litter day 5 ( ± SD) 11.2 ± 2.9 11.3 ± 1.9 10.6 ± 2.5 9.1 ± 3.3 2.1 ± 4.5t -
Surviving on day 5, % 95.2 91.4 89.9 85.6 46.9
No. of litters with deaths day 1-5 4/14 6/15 8/15 10/15 6/7
No. of litters with more than one death day 1-5 2/15 2/15 2/15 7/15 4/7
*Statistically significantly different from the control group means at 95% level Student t test.
'Statistically significantly different from the control group means at 99% level, Student t test, two-sided.
Table 3. Effect of route of administration on teratogenic potential of EGME.
Mean pup Mean pup
Number Number of Mean litter weight, Mean litter Survival, weight, % Weight
Treatment and route pregnant litters size, day 0 day 0, g size, day 4 % day 4, g gain (pups)
10 mL/kg saline IP 15 12 7.6 5.3 5.4 64 8.8 43
200 mg/kg EGME IP 15
10 mL/kg saline PO 15 15 10.7 6.1 10.7 99 9.0 48
200 mg/kg EGME PO 15 0
2 mL/kg saline SC 15 15 10.8 6.0 10.5 91 9.25 52
40 mg/kg EGME SC 15 7 4.6* 6.0 2.1* 23* 10.7 31
250 mg/kg EGME SC 15 0
2 mL/kg saline dermally 15 15 13.2 5.6 12.7 96 9.2 59
40 mg/kg EGME dermally 15 15 12.7 5.9 12.3 97 9.4 98
Control 20 20 11.5 6.0 11.5 99 7.0 17
100 ppm EGME, inhalation 20 9 3.3* 6.2 4.0* 49* 6.5 - 15*
300 ppm EGME, inhalation 20 0
*Statistically significantly different from control (p < 0.05).
inhalation (4) and ingestion (2). The work reported here
forms a comparison of the results of using EGME as
a positive control in several studies to determine the
teratogenic potential ofa variety ofcompounds. EGME
has been given by the followingroutes duringthe course
of these studies: intraperitoneally, orally, subcutane-
ously, dermally and byinhalation. The results are shown
in Table 3. It will be seen that 200 to 250 mg/kg of
EGME caused complete loss of litters by the intra-
peritoneal route, by the oral route, and when given
subcutaneously; 300 ppm ofEGME by inhalation, which
corresponds approximately to a dose of 350 mg/kg
assuming 100% retention, caused a similar result. At
lower doses, EGME causes a loss ofapproximately half
the litters, with reduced litter size and survivability in
the pups. This is shown by 40 mg/kg EGME subcutane-
ously and 100 ppm EGME by inhalation (which corres-
ponds to an approximate dose of 115 mg/kg assuming
100% retention). Interestingly, a similar dose adminis-
tered dermally, i.e., 40 mg/kg EGME, had no effect on
the developing fetus. This result indicates that the skin
has some barrier function with regard to EGME.
Effect of Ethylene Glycol
Monoisopropyl Ether (EGPE) on the
Testis and Blood of Rats
Groups of 10 male Alpk/Ap (Wistar-derived) rats
were exposed to air, 300 or 1000 ppm of EGPE for 6
hr/day for 5 days ofweek 1 and for 4 days ofweek 2. On
the dayfollowingthe lastexposure, the rats were killed,
blood samples weretaken, and the testes wereweighed.
Rats in the 1000 ppm EGPE group showed marked
hematuria onthe first day ofexposure; subsequently, no
more hematuria was seen. The skin of these rats was
pale in appearance up to and including day 4; subse-
quently their clinical condition appeared comparable to
the controls. The body weight gains of the rat in the
1000 ppm EGPE group were statistically significantly
lower than the controls, while the rats in the 300 ppm
groups had weightgains similarto the control group. At
postmortem the appearance and weights of the testis
from both the 1000 and 300 ppm groups were similar to
the controls.
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At 1000 ppm, statistically significant reductions were
seen in hemoglobin concentration, red blood cell count
and mean corpuscular hemoglobin concentrations. In
addition, mean cell volumes and mean cell hemoglobin
were statistically significantly higher in the 1000 ppm
group. These changes are consistent with the initial
hematuria observed in these rats. There were no
changes in the white blood cell counts, and apart from a
slight increase in mean cell volume there were no
hematological effects in the rats exposed to 300 ppm
EGPE. This study indicates that EGPE behaves in a
similar manner to ethylene glycol monobutyl ether
(EGBE) (9), i.e., the major effect appears to be
hemolysis, followed by replacement with resistant cells
which are younger and larger. There was no suggestion
of the typical response seen with EGME of testicular
atrophy and leukocytopenia.
sure and throughout a subsequent 14-day observation
period. On day 15 the animals were killed by over
exposure to halothane and subjected to gross macro-
scopic postmortem examination, which included the
weighing ofthe testes. The results are shown in Table 4.
Both EGME and EGEE caused reductions in testis
weight when compared with the controls on day 15,
EGME causing an approximately 50% reduction and
EGEE a 20% reduction. Neither EGPE nor EGBE
caused a reduction in testes weight. Clinical observa-
tions also revealed another sign associated with the
glycol ethers, hematuria in the animals treated with
EGEE, EGPE or EGBE. EGME did not cause hema-
turia. These limited data indicate that both EGME
and EGEE can cause testicular atrophy after a single,
albeit, veryhigh, exposure byinhalation. However, even
the saturated vapor from EGPE and EGBE did not
cause testicular atrophy.
Effect of a Single Inhalation Exposure
to Ethylene Glycol Monoalkyl Ethers Effect of a Single Exposure to
(EGME, EGEE, EGPE, EGBE) EGME on the Testis of Male Rats
Ethylene glycol monomethyl ether (EGME) has been
shown to cause testicular atrophy following 90 days
exposure (10) and 10 days exposure (4,7). In these
studies, 300 ppm (= 960 mg/mr3) caused testicular
atrophy. The work reported here was designed to assess
whether a single very high exposure to EGME would
also cause testicular atrophy. In order to determine
whether there is a clear structure activity relationship,
ethylene glycol monoethyl (EGEE), monoisopropyl
(EGPE) and monobutyl (EGBE) ethers were also
examined in the same experiment. Male 250 g Alpk/Ap
(Wistar-derived) rats were exposed for 3 or 4 hr to the
saturated vapor generated by blowing air through the
relevant test material contained in a sintered glass
bubbler. The undiluted vapor was led into 1 L glass
exposure chambers, each containing five rats housed
individually. The atmosphere concentrations were esti-
mated by dividing the weight loss from the bubbler by
the total airflow. The rats were observed during expo-
nble 4. Comparative data on effect of exposure to saturated
vapor of glycol ethers on testis weights at day 15.
Testis weight, % of body weight
Hematuria
Compound and (Present
concentration 3-hr exposure Control or absent)
EGME, 24 mg/L 0.49 ± 0.08 1.06 ± 0.06
(7500 ppm)
EGEE, 17 mg/L 0.78 ± 0.07 1.06 ± 0.06 +
(4500 ppm)
EGPE, 15 mg/L 0.95 0 0.092 0.98 ± 0.10 +
(3500 ppm)
EGBE, 4 mg/L 0.95 ± 0.06 0.93 ± 0.05 +
(800 ppm)
'4-hr exposure.
*Statistically different from control (Student's t-test, p < 0.05).
The previous study had shown that EGME is capable
ofcausing testicular weight loss after a single exposure
to a saturated vapor. These studies were designed to
determine the dose-response relationship of the effect
of the single exposure on the testes, to determine the
histological effect, and to determine the time course of
the onset of testicular damage.
In the first study, groups of 20 male Alpk/AP rats
were exposed to 5000, 2500, 1250, 625, 300 or 150 ppm
EGME. A further group ofrats was exposed to air only.
Following exposure which took place in 3.4 m3 whole
body exposure chambers, they were returned to their
holding cages for 13 days, and 14 days after treatment,
were killed with an overdose of halothane. At autopsy
the left and right testis were weighed separately and
stored in Bouin's fixative for subsequent processing and
microscopic examination. The caudalepididymides were
weighed together and preserved for processing and
microscopic examination. The accessory glands, semi-
nal vesicle and ventral prostate were weighed and later
examined histopathologically.
There was a dose-related fall in body weight gain
as shown by the body weight immediately before
postmortem. These were accompanied by a dose-related
fall in testes weight which was significant down to 1250
ppm (Fig. 2). There were reductions in the caudal
epididymidal weight and an increase in the accessory
gland weight at 5000 ppm of EGME. Histological
examination of the testes revealed severe bilateral
tubular atrophy with disordered spermatogenesis in
rats exposed to 5000 ppm EGME for 4 hr, with many
tubules showing only stem cells and Sertoli cells.
Similar, though less marked changes, were seen in rats
exposed to 2500 and 1250 ppm EGME. Although testes
weight was not reduced at 625 ppm EGME, maturing
spermatids showed evidence of damage.
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FIGURE 2. Effect on rat testis weight of a single exposure of EGME. Significance as in Figure 1.
Inthe second study, groups of90, 8-week-old Alpk/AP
rats were exposed to either 2500 or 1000 ppm EGME
for a single 4-hr period. A further group of90 rats was
sham-exposed to air. Ten rats per group were killed on
each of days 1, 2, 3, 4, 5, 8, 10, 15 and 19 following
exposure. Individual body weights were recorded on
the day before exposure and subsequently on days 4, 8,
15 and 19. Testes, epididymides and accessory gland
weights were recorded at autopsy. Samples of these
tissues were preserved in Bouin's fixative prior to
examination. The results are shown in Figure 3.
In the second study, testis weight reduction was seen
in exposed rats 48 hr after exposure to both 2500 and
1000 ppm, and testes weights were lower than control
values in both the exposed groups at subsequent time
points. Histological examination of the testes revealed
damage to the germinal epithelium 24 hr after exposure
with primary spermatocytes as the target cells for
EGME. Recovery was not evident at day 19 following
exposure to 2500 ppm EGME, and the germinal epithe-
lium remained disordered. Electron microscopy re-
vealed changes in the Sertoli cells, with cytoplasmic
retraction and swollen mitochondria evident 4 days after
exposure to EGME. There was a biphasic response in
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FIGURE 3. Time course of the effect of a single exposure of EGME in male rats. Significance as in Figure 1.
exposed animals with regard to epididymal weight. The
increased weight at day 4 probably reflects the passage
through the epididymides at this point oflarge numbers
of immature germ cells shed from the testes following
the initial insult. Subsequently, epididymal weights
were reduced when compared to control values, again
reflecting the situation in the testes where there was a
marked reduction in the number of spermatozoa pro-
duced following exposure. EGME would appear to be
exerting its effect primarily on rapidly dividing cells,
with primary spermatocytes being affected initially.
Subsequently, Sertoli cells showed signs ofdamage and
this may account for the resulting marked loss of
immature germ cells.
These studies indicate that even a relatively short
exposure to EGME vapor can caused marked testicular
atrophy although at high concentrations. Even at con-
centrations comparable with those causing testicular
atrophy over a 90-day period (i.e., 300 ppm versus
625 ppm), there were subtle effects on spermato-
genesis highlighting the need for further study of the
effect of EGME on the testes. The results were
reported previously (11).
General Conclusion
The work reported in this paper demonstrates very
clearly the role oftoxicology examinations which do not
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fall clearly into the type of testing currently done for
regulatory purposes. BoththetesticulareffectofEGME
and the effect on the developing fetus can be seen in
relatively short term and/or inexpensive experiments.
The effect of EGME on the testis has been shown after
10 days exposure orindeed after a single exposure. This
has enabled the effect of other glycol ethers to be
examined very quickly. These data were in many cases
generated before the effects ofthe otherglycol ethers in
regulatory type studies were available and where this
has occurred these studies have accurately predicted
the effect in the regulatory studies. Thus, EGME has
been shown to affect the testis (10). EGBE on the other
hand, does not appear to affect the testis in a similar
manner (9). It is therefore reasonable to assume that
EGPE which did not affect the testes weights after
either 10 days exposure at 1000 ppm or 4 hr exposure to
a saturated vapor would not cause testicular atrophy in
a longer regulatory study.
The effect of EGME upon the developing embryo is
dramatically revealed using the test for teratogenic
potential (6).
At higher levels EGME causes complete resorption of
all embryos and at lower levels all three of the factors
suggested by Chernoff and Kavlock (6) affected, i.e.,
numbers oflitters, numbers ofpups, their survivability
to day 4. Again, these results are in agreement with the
results of full teratology studies which have been
carried out with EGME. EGME has been shown to be
fetotoxic and teratogenic in the rabbit (10) and in
the mouse (2). This activity of EGME gives added
confidence to the results found with PGME and with
diEGME in this test. Even though EGME has such a
dramatic effect, neither PGME nor diEGME caused
any significant changes in the parameters listed by
Chernoff and Kavlock (6). It is important to remember,
however, that in both the studies reported here the dose
oftest compound was not so high that there was severe
maternal toxicity. It is important when trying to
interpret the results ofthis type of study that extrava-
gantly high doses are not used. These studies give a fair
amount ofconfidence inpredictingthatneitherdiEGME
nor PGME will be significantly teratogenic.
Taken overall, these studies indicate that even with a
limited resource in terms of time and availability of
experimental facilities, significant knowledge can be
gained on the toxicology of a group of compounds,
provided that a good positive control substance, such as
EGME, is available.
The studies reported here were carried out as a collaborative effort
by I. S. Chart, D. Hart, L. K. Head, S. Millward, L. Pinto, D. M.
Samuels, D. J. Tinston, G. A. Wickramaratne and D. R. Woodcock.
Thanks are also due to Miss L. Pritchard for typing this manuscript.
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